Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Powerful Immune System Against Powerful Covid-19: A Hypothesis Publisher Pubmed



Taghizadehhesary F1 ; Akbari H1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Traditional Medicine School, Tehran University of Medical Sciences, Tehran, Iran

Source: Medical Hypotheses Published:2020


Abstract

On March 11, 2020, the World Health Organization declared the coronavirus outbreak a pandemic. Since December 2019, the world has experienced an outbreak of coronavirus disease 2019 (COVID-19). Epidemiology, risk factors, and clinical characteristics of patients with COVID-19 have been reported but the factors affecting the immune system against COVID-19 have not been well described. In this article, we provide a novel hypothesis to describe how an increase in cellular adenosine triphosphate (c-ATP) can potentially improve the efficiency of innate and adaptive immune systems to either prevent or fight off COVID-19. © 2020 Elsevier Ltd
Related Docs
View other Related Docs
1. Mitochondria Determine Response to Anti-Programmed Cell Death Protein-1 (Anti-Pd-1) Immunotherapy: An Evidence-Based Hypothesis, Mitochondrion (2022)
2. Potential Antiviral Immune Response Against Covid-19: Lessons Learned From Sars-Cov, Advances in Experimental Medicine and Biology (2021)
3. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
4. Precision Medicine in Infectious Disease, Precision Medicine in Clinical Practice (2022)
5. A Perspective on Erythropoietin As a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients With Covid-19, Archives of Medical Research (2020)
6. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
7. Th17 and Treg Cells Function in Sars-Cov2 Patients Compared With Healthy Controls, Journal of Cellular Physiology (2021)
8. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Atabak Najafi (1)
Other Related Docs
9. Covid-19 Induced Liver Injury From a New Perspective: Mitochondria, Mitochondrion (2023)
10. Targeted Anti-Mitochondrial Therapy: The Future of Oncology, Genes (2022)
11. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)
12. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
13. Immune Responses and Pathogenesis of Sars-Cov-2 During an Outbreak in Iran: Comparison With Sars and Mers, Reviews in Medical Virology (2020)
14. Melatonin Could Be Beneficial in Sars-Cov-2 Therapy, Natural Products Journal (2021)
15. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
16. Do Interferons Play a Role in Covid-19?, International Journal of Clinical Practice (2021)
17. Effect of Cytokines Gene Expression and Serum Level of Vitamin D on the Severity of Covid-19, Iranian Journal of Medical Microbiology (2022)
18. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
19. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
20. Omega-3 Polyunsaturated Fatty Acids Supplementation Improve Clinical Symptoms in Patients With Covid-19: A Randomised Clinical Trial, International Journal of Clinical Practice (2021)
21. Comparison of Immune Response Between Sars, Mers, and Covid-19 Infection, Perspective on Vaccine Design and Development, BioMed Research International (2021)